stock logo

50% Buy

Aarti Drugs Share Price

AARTIDRUGS

₹487.25+₹3.35 (0.69%) TodayLast updated on 05 Nov, 2024 | 15:08 IST

Aarti Drugs Share Price Chart

Please wait...
  • About Aarti Drugs
  • Fundamentals
  • Events
  • More
  • News

About Aarti Drugs

Aarti Drugs Financials

arrow
Market cap
Market Cap Switch₹4,417 Crs
Open
₹484.05
Close
₹483.90
Circuit range
₹580.65 - ₹387.15
Day range
₹480.80 - ₹491.55
Year range
₹431.05 - ₹635.00
Volume
87,088
Avg. traded
₹486.07
Revenue (12m)
₹2,380 Crs
Aarti DrugsAarti Drugs Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals includes benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

Aarti Drugs Key indicators

arrow
52 week high
₹635.00
52 week low
₹431.05
P/E ratio
29.12
P/B ratio
3.46
ROE
12.39%
ROCE
13.7%
Dividend yield
0.2%
Debt/Equity ratio
0.4
EPS
15.43

Learn more

Investment checklist: (3/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

50%

Hold

50%

Sell

0%

This analysis is based on the reviews of 2 experts in the last 7 days

Aarti Drugs Fundamentals

Aarti Drugs Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

12.06%

Net profit margin

6.26%

ROE

12.39%

ROA

6.5%

ROCE

13.7%

Learn more

Aarti Drugs Shareholder returns

arrow
1 day
-0.80%
1 week
+0.02%
1 month
-6.28%
3 months
-5.38%
1 year
+5.18%
3 years
-16.11%
5 years
+267.57%

Aarti Drugs Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹490.00
₹483.90
-0.80%
Fri, Nov 1 2024
₹484.15
₹487.80
+0.75%
Thu, Oct 31 2024
₹484.75
₹484.15
-0.11%
Wed, Oct 30 2024
₹486.60
₹484.70
+0.13%
Tue, Oct 29 2024
₹484.30
₹484.05
+0.05%
Mon, Oct 28 2024
₹477.20
₹483.80
+1.92%
Fri, Oct 25 2024
₹471.00
₹474.70
-2.10%
Thu, Oct 24 2024
₹488.95
₹484.90
-0.66%

Aarti Drugs Shareholding Pattern

arrow

Promoters (55.64%)

Mutual Funds (6.25%)

Retail and other (34.02%)

Foreign institutions-FII (2.5%)

Other domestic institutions (1.59%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹1/share

    Ex date 06 Feb 2024

    expand tab
  • Dividend • ₹1/share

    Ex date 08 Feb 2023

    expand tab
  • Dividend • ₹1/share

    Ex date 09 Feb 2022

    expand tab

Learn more

FAQs on Aarti Drugs